Genmab A/S (GMAB)
27.66
-1.99
(-6.71%)
USD |
NASDAQ |
Mar 03, 16:00
27.91
+0.25
(+0.90%)
After-Hours: 06:47
Genmab Total Liabilities (Quarterly) : 7.026B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie, Inc. | 137.19B |
| Novo Nordisk A/S | 54.85B |
| Krystal Biotech, Inc. | 114.23M |
| Ascendis Pharma A/S | 1.721B |
| Zealand Pharma A/S | 256.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.87B |
| Shareholders Equity (Quarterly) | 5.847B |
| Debt to Equity Ratio | 0.928 |
| Current Ratio | 2.022 |
| Net Debt Paydown Yield | -5.56% |